Growth Metrics

Iridex (IRIX) Current Deferred Revenue (2016 - 2026)

Iridex has reported Current Deferred Revenue over the past 16 years, most recently at $9.0 million for Q1 2026.

  • For Q1 2026, Current Deferred Revenue rose 311.81% year-over-year to $9.0 million; the TTM value through Jan 2026 reached $9.0 million, up 311.81%, while the annual FY2026 figure was $9.0 million, 311.81% up from the prior year.
  • Current Deferred Revenue for Q1 2026 was $9.0 million at Iridex, up from $2.2 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $14.9 million in Q3 2022 and troughed at $2.1 million in Q1 2025.
  • A 5-year average of $5.4 million and a median of $2.4 million in 2022 define the central range for Current Deferred Revenue.
  • Biggest five-year swings in Current Deferred Revenue: soared 982.72% in 2022 and later tumbled 84.5% in 2023.
  • Year by year, Current Deferred Revenue stood at $14.2 million in 2022, then dropped by 12.18% to $12.4 million in 2023, then tumbled by 82.49% to $2.2 million in 2024, then increased by 1.47% to $2.2 million in 2025, then soared by 305.84% to $9.0 million in 2026.
  • Business Quant data shows Current Deferred Revenue for IRIX at $9.0 million in Q1 2026, $2.2 million in Q3 2025, and $2.3 million in Q2 2025.